The role of epinephrine in the treatment of anaphylaxis

被引:19
|
作者
Ellis, AK [1 ]
Day, JH [1 ]
机构
[1] Kingston Gen Hosp, Div Allergy, Kingston, ON K7L 2V7, Canada
关键词
D O I
10.1007/s11882-003-0004-y
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Epinephrine is the cornerstone of anaphylaxis management. Its administration should be immediate upon evidence of the occurrence of anaphylaxis. Delays in administration may be fatal. The most appropriate administration is 0.3 to 0.5 mL of 1:1000 dilution intramuscularly for adults and 0.01 mg/kg for children, given in the lateral thigh. Patients with known anaphylactic reactivity should be prescribed an epinephrine auto-injector to be carried at all times for treatment of potential recurrences. Education of the patient or parent regarding the proper use of this tool is paramount.
引用
收藏
页码:11 / 14
页数:4
相关论文
共 50 条
  • [31] Access barriers to epinephrine autoinjectors for the treatment of anaphylaxis: A survey of practitioners
    Ponda, Punita
    Russell, F. Anne
    Yu, E. Joyce
    Land, H. Michael
    Crain, G. Maria
    Patel, Kiran
    Shroba, A. Jodi
    Sriaroon, Panida
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (10): : 3814 - +
  • [32] Treatment with Epinephrine (Adrenaline) in Suspected Anaphylaxis during Anesthesia in Denmark
    Garvey, Lene H.
    Belhage, Bo
    Kroigaard, Mogens
    Husum, Bent
    Malling, Hans-Jorgen
    Mosbech, Holger
    ANESTHESIOLOGY, 2011, 115 (01) : 111 - 116
  • [33] Intramuscular versus subcutaneous injection of epinephrine in the treatment of anaphylaxis - Reply
    Simons, FER
    Gu, XC
    Simons, KJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (04) : 720 - 721
  • [34] Factors Associated With Epinephrine Use in the Treatment of Anaphylaxis in Infants and Toddlers
    Pistiner, Michael
    Mendez-Reyes, Jose Euberto
    Eftekhari, Sanaz
    Carver, Melanie
    Lieberman, Jay
    Wang, Julie
    Camargo, Carlos A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2024, 12 (02): : 364 - 371.e1
  • [35] Bioavailability and Stability of an Epinephrine Nasal Powder Formulation for Treatment of Anaphylaxis
    Jonsson, Martin
    Savmarker, Jonas
    Coburn, Robert
    Ruden, Jonas
    Ohlund, David
    Ronn, Robert
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB367 - AB367
  • [36] Sublingual epinephrine tablets versus intramuscular injection of epinephrine: Dose equivalence for potential treatment of anaphylaxis
    Rawas-Qalaji, MM
    Simons, FER
    Simons, KJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (02) : 398 - 403
  • [37] Effectiveness of delayed epinephrine in anaphylaxis
    Hare, Nathaniel D.
    Ballas, Zuhair K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) : 716 - 717
  • [38] The Dose of Epinephrine to Treat Anaphylaxis
    Russell, W. John
    ANESTHESIOLOGY, 2010, 112 (06) : 1542 - 1542
  • [39] Epinephrine for anaphylaxis underused in Europe
    Grabenhenrich, L. B.
    Dolle, S.
    Rueff, F.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 124 (02) : 214 - 214
  • [40] When is epinephrine prescribed for anaphylaxis?
    Alvarez-Perea, Alberto
    Tomas-Perez, Margarita
    Ameiro, Beatriz
    Zubeldia, Jose M.
    Baeza, Maria L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 122 (03) : 339 - 340